FIELD: organic chemistry and medicine.
SUBSTANCE: invention relates to the field of organic chemistry and medicine, namely to the use of 1,3-bis(perfluoro-tert-butyl)propane as a contrast agent for magnetic resonance imaging on 19F nuclei. Preferably, 1,3-bis(perfluoro-tert-butyl)propane is used in living subjects as a nanoscale aqueous emulsion.
EFFECT: creation of contrast agent for magnetic resonance imaging.
2 cl, 5 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 1,2-BIS(PERFLUORO-tert-BUTOXY)ETHANE AS A CONTRAST FOR F NUCLEUS MAGNETIC RESONANCE IMAGING | 2022 |
|
RU2795915C1 |
| CONTRAST AGENT FOR INTRODUCTION OF FLUORINE-19 LABEL INTO PROTEINS CONTAINING LYSINE RESIDUES | 2015 |
|
RU2599500C1 |
| ELIMINATION OF INVOLVEMENT OF CONTRAST AGENT CONCENTRATION IN MRT | 2007 |
|
RU2446829C2 |
| PHYSIOLOGICALLY ACCEPTABLE EMULSIONS CONTAINING PERFLUOROHYDROCARBON ETHER HYDRIDES AND METHODS FOR UTILIZATION THEREOF | 1995 |
|
RU2159610C2 |
| NEW GADOLINIUM CHELATE COMPOUNDS WITH HIGH RELAXIVITY FOR USE IN MAGNETIC RESONANCE IMAGING | 2017 |
|
RU2755181C2 |
| REAGENT FOR INTRODUCTION OF PERFLUORO-TERT-BUTYL GROUP, METHOD FOR PRODUCTION THEREOF AND METHOD FOR PRODUCING PERFLUORO-TERT-BUTYL-SUBSTITUTED COMPOUNDS | 2015 |
|
RU2602240C1 |
| PERFLUOROALKYL-CONTAINING COMPLEXES WITH POLAR RESIDUES, METHOD FOR THEIR PREPARING, PHARMACEUTICAL AGENT | 2001 |
|
RU2289579C2 |
| 2-BROMOTETRAFLUOROETHYLPERFLUOROALKYL ESTERS FOR PRODUCING EMULSIONS FOR MEDICAL AND BIOLOGICAL PURPOSES | 2017 |
|
RU2696871C2 |
| METHOD FOR PREPARING CONTRAST PREPARATION BASED ON HUMAN SERUM ALBUMIN FOR VISUALIZING TUMOUR TISSUES | 2016 |
|
RU2629844C1 |
| METHOD FOR PRODUCTION OF VIC-DICHLOROFLUOROANHYDRIDE | 2000 |
|
RU2252210C2 |
